Washington Report

Jun 01, 2010
Pharmaceutical Executive
FDA and industry seek to ensure drug quality in a world complicated by global outsourcing and theft.
May 01, 2010
Pharmaceutical Executive
Under the new healthcare regime, pharma will ante up fees and rebates in return for expanded sales and safeguards.
Apr 01, 2010
Pharmaceutical Executive
FDA Commissioner Margaret Hamburg looks to bolster the agency's scientific expertise.
Mar 01, 2010
Pharmaceutical Executive
FDA's new Sentinel System is going live, but the signals may be difficult to assess.
Feb 01, 2010
Pharmaceutical Executive
R&D is surging, but new methods and data raise new manufacturing and regulatory challenges.
Jan 01, 2010
Pharmaceutical Executive
Pharma must confront regulatory and marketing challenges in a global competitive environment.
Dec 01, 2009
Pharmaceutical Executive
They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.
Nov 01, 2009
Pharmaceutical Executive
FDA and Congress weigh policies for improving drug safety via ads and written information.
Oct 01, 2009
Pharmaceutical Executive
All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.
Sep 01, 2009
Pharmaceutical Executive
Pharma steps up development of new vaccines and treatments to combat Third World diseases
native1_300x100
lorem ipsum